USA - NASDAQ:TALK - US87427V1035 - Common Stock
The current stock price of TALK is 3.25 USD. In the past month the price increased by 17.75%. In the past year, price increased by 6.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.36 | 98.69B | ||
| CI | THE CIGNA GROUP | 9.49 | 71.98B | ||
| LH | LABCORP HOLDINGS INC | 16.87 | 22.18B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.15 | 20.90B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.07 | 19.17B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.77B | ||
| DVA | DAVITA INC | 13.17 | 8.69B | ||
| HIMS | HIMS & HERS HEALTH INC | 68.48 | 8.36B | ||
| CHE | CHEMED CORP | 19.8 | 6.35B | ||
| RDNT | RADNET INC | 197.76 | 5.78B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.37 | 5.67B | ||
| OPCH | OPTION CARE HEALTH INC | 19.07 | 4.61B |
Talkspace, Inc. engages in the operation and development of a technology platform used in connecting patients to licensed mental health professionals through messaging, video, and audio. The company is headquartered in New York City, New York and currently employs 521 full-time employees. The company went IPO on 2020-06-09. The firm offers a suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). Through its psychotherapy offerings, the Company’s licensed therapists and counselors treat mental health conditions in over 150 clinical conditions, such as depression, anxiety, trauma and other fields of human challenges. The firm serves health insurance plans and employee assistance programs (Payor) who offer their members access to the Company’s platform at in-network reimbursement rates. In psychotherapy, the Company offers text, audio and video-based psychotherapy from licensed therapists. In psychiatry, members receive personalized care from a prescriber who specializes in mental healthcare and prescription management.
TALKSPACE INC
622 Third Avenue
New York City NEW YORK US
CEO: Douglas G. Bergeron
Employees: 521
Phone: 12122847206
Talkspace, Inc. engages in the operation and development of a technology platform used in connecting patients to licensed mental health professionals through messaging, video, and audio. The company is headquartered in New York City, New York and currently employs 521 full-time employees. The company went IPO on 2020-06-09. The firm offers a suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). Through its psychotherapy offerings, the Company’s licensed therapists and counselors treat mental health conditions in over 150 clinical conditions, such as depression, anxiety, trauma and other fields of human challenges. The firm serves health insurance plans and employee assistance programs (Payor) who offer their members access to the Company’s platform at in-network reimbursement rates. In psychotherapy, the Company offers text, audio and video-based psychotherapy from licensed therapists. In psychiatry, members receive personalized care from a prescriber who specializes in mental healthcare and prescription management.
The current stock price of TALK is 3.25 USD. The price increased by 0.62% in the last trading session.
TALK does not pay a dividend.
TALK has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
TALKSPACE INC (TALK) currently has 521 employees.
TALKSPACE INC (TALK) has a market capitalization of 544.28M USD. This makes TALK a Small Cap stock.
ChartMill assigns a technical rating of 9 / 10 to TALK. When comparing the yearly performance of all stocks, TALK is one of the better performing stocks in the market, outperforming 81.46% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to TALK. While TALK has a great health rating, there are worries on its profitability.
Over the last trailing twelve months TALK reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS increased by 400% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.98% | ||
| ROA | 3.29% | ||
| ROE | 3.89% | ||
| Debt/Equity | 0 |
13 analysts have analysed TALK and the average price target is 4.9 USD. This implies a price increase of 50.65% is expected in the next year compared to the current price of 3.25.
For the next year, analysts expect an EPS growth of 274.03% and a revenue growth 20.61% for TALK